share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director George Simeon

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director George Simeon

CRISPR Therapeutics | 4：持股變動聲明-董事 George Simeon
美股sec公告 ·  05/31 16:54
Moomoo AI 已提取核心訊息
In a recent transaction, George Simeon engaged with CRISPR Therapeutics AG, trading under the symbol CRSP, on May 30, 2024. The details of the transaction, including the number of shares involved and the nature of the transaction, have not been disclosed. As of now, the relationship of George Simeon to the issuer remains unspecified. Investors are advised to note the date of the transaction for their records.
In a recent transaction, George Simeon engaged with CRISPR Therapeutics AG, trading under the symbol CRSP, on May 30, 2024. The details of the transaction, including the number of shares involved and the nature of the transaction, have not been disclosed. As of now, the relationship of George Simeon to the issuer remains unspecified. Investors are advised to note the date of the transaction for their records.
在最近的一筆交易中，喬治·西蒙於2024年5月30日與CRISPR Therapeutics AG進行了交易，股票代碼爲CRSP。該交易的細節，包括所涉及的股票數量和交易的性質，尚未披露。截至目前，喬治·西蒙與發行人的關係仍未明確。建議投資者記下交易日期以備記錄。
在最近的一筆交易中，喬治·西蒙於2024年5月30日與CRISPR Therapeutics AG進行了交易，股票代碼爲CRSP。該交易的細節，包括所涉及的股票數量和交易的性質，尚未披露。截至目前，喬治·西蒙與發行人的關係仍未明確。建議投資者記下交易日期以備記錄。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息